Safety and Efficacy of Therapies for Skin Symptoms of Psoriasis in Patients with Psoriatic Arthritis: A Systematic Review

    Authors

    W. H. Boehncke; D. A. Martinez; J. A. Solomon;A. B. Gottlieb

    Comments

    Authors: contact us about adding a copy of your work at STARS@ucf.edu

    Abbreviated Journal Title

    J. Rheumatol.

    Keywords

    PSORIASIS; PSORIATIC ARTHRITIS; THERAPY; EFFICACY; PSORIASIS AREA AND; SEVERITY INDEX; PLACEBO-CONTROLLED TRIAL; SEVERE PLAQUE PSORIASIS; DOUBLE-BLIND; PHASE-II; CERTOLIZUMAB PEGOL; CLINICAL-TRIAL; CYCLOSPORINE-A; METHOTREXATE; MODERATE; MULTICENTER; Rheumatology

    Abstract

    Numerous guidelines and recommendations exist for the treatment of psoriasis in various populations. One important population is patients with psoriatic arthritis (PsA) who have symptoms of both joint and skin disease. In patients with both facets of psoriatic disease, skin and joints must be treated separately, but also simultaneously. As several systemic therapies are approved for either one or both, the concept of treating both facets with the same drug is feasible. This review summarizes evidence from studies in patients with PsA on the efficacy of these drugs on psoriatic skin disease in these patients.

    Journal Title

    Journal of Rheumatology

    Volume

    41

    Issue/Number

    11

    Publication Date

    1-1-2014

    Document Type

    Review

    Language

    English

    First Page

    2301

    Last Page

    2305

    WOS Identifier

    WOS:000344598900033

    ISSN

    0315-162X

    Share

    COinS